Interventional Cardiology Devices Market Will Generate Record Revenue by 2029

The global interventional cardiology devices market is anticipated to grow at a significant CAGR of 7.1% during the forecast period. Interventional cardiology is the subspecialty of cardiology that uses specialized catheter-based techniques to diagnose and treat coronary artery disease, vascular disease, structural heart disease, and congenital heart defects. The interventional cardiology devices market is experiencing growth owing to the increased investment from established market players as well as the emergence of new start-ups globally. These investments are fostering the rapid development of advanced devices thereby improving treatment options for patients with cardiovascular conditions.

For instance, in March 2023, Magenta Medical, raised a $55 million financing round led by global healthcare investment manager OrbiMed, with participation from existing investors New Enterprise Associates (NEA), Pitango VC, and ALIVE - Israel Health Tech Fund. The financing will be used, among other things, to advance the clinical programs of the company's product in the United States toward its first FDA approval. The company is developing Magenta's percutaneous Left Ventricular Assist Device (VAD). It is a compact heart pump that is inserted through the groin and expands inside the left ventricle. It adjusts pump flow based on the patient's condition, allowing the heart to rest and promote recovery. Also, in September 2022, Terumo Cardiovascular, a company that makes medical devices for heart and blood vessel surgeries, opened a new factory in Costa Rica. This factory will make special equipment for heart surgeries. Terumo invested $42 million in its global manufacturing operations to enhance its manufacturing capabilities.

Furthermore, the established market players are strategically involved in expanding their product portfolio, thereby propelling the growth of the market. For instance, in February 2023, Abbott, a medical technology company, announced to buy Cardiovascular Systems, a company that makes devices for removing plaque from blood vessels. Abbott will pay $20 for each share of Cardiovascular Systems, which adds up to a total of about $890 million. After the acquisition, Cardiovascular Systems devices will become part of Abbott's products for treating vascular diseases. This includes guidewires, catheters, and devices used to remove plaque from blood vessels.

To Request a Sample of our Report on Interventional Cardiology Devices Market: https://www.omrglobal.com/request-sample/interventional-cardiology-devices-market

Market Coverage

• The market number available for - 2023-2030

• Base year- 2022

• Forecast period- 2023-2030

Segment Covered-

· By Product Types

· By End Users

Regions Covered-

· North America

· Europe

· Asia-Pacific

· Rest of the World

Competitive Landscape- Includes Boston Scientific Corporation, Medtronic PLC, Abbott Laboratories, Edwards Lifesciences Corp., Edward Lifesciences Corp., Terumo Corp., and B. Braun Melsungen AG., and others.

A full Report of Interventional Cardiology Devices Market is Available @ https://www.omrglobal.com/industry-reports/interventional-cardiology-devices-market

Interventional Cardiology Devices Market Report Segment

By Product Types

· Catheters

· PTCA Guidewires

· Stents

· Balloon Inflation Device

· PTCA Balloons

By End Users

Hospitals
Cardiac Catheterization Laboratories
Ambulatory Surgical Centers
Cardiac Clinics
Academic and Research Institutions
Interventional Cardiology Devices Market Report Segment

By Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

• Latin America

• Middle East and Africa

Company Profiles

· Balton Sp. z o.o.

· Biosensor International

· Biotronik SE & Co. KG

· Cardinal Health, Inc.

· Comed B.V.

· Edwards Lifesciences Corp.

· Endocor GmbH

· iVascular S.L.U.

· Johnson & Johnson

· Koninklijke Philips N.V.

· Medinol Ltd.

· Penumbra, Inc.

· Rontis AG

· Scitech

· SMT (Sahajanand Medical Technologies Pvt. Ltd.)

· Stentys SA

· Terumo Corp.

· WELLINQ

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/interventional-cardiology-devices-market

https://www.culturespace.co.kr/news-%eb%ac%b8%ed%99%94%e8%a1%97/light-fidelity-li-fi-%ea%b0%80%ec%8b%9c-%ea%b4%91%ec%84%a0-%ed%86%b5%ec%8b%a0-%ec%8b%9c%ec%9e%a5-%ec%84%b1%ec%9e%a5%eb%a5%a0-%ec%82%b0%ec%97%85-%ec%83%81%ed%83%9c-2029-%eb%85%84%ea%b9%8c/178244/
https://perualdia.net/es-probable-que-el-mercado-de-tuberias-termoplasticas-experimente-un-crecimiento-tremendo-para-2029/

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.